CorMedix, Inc. (CRMD)
7.69
+0.34
(+4.63%)
USD |
NASDAQ |
Feb 06, 16:00
7.675
-0.02
(-0.20%)
After-Hours: 20:00
CorMedix SG&A Expense (TTM) : 75.56M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 353.07M |
| Pfizer Inc. | 13.79B |
| Arcutis Biotherapeutics, Inc. | 253.18M |
| ANI Pharmaceuticals, Inc. | 304.67M |
| Castle Biosciences, Inc. | 222.56M |